Literature DB >> 12202875

Incorporation and integration of implanted myogenic and stem cells into native myocardial fibers: anatomic basis for functional improvements.

Edgar G Chedrawy1, Jih-Shiuan Wang, Dao M Nguyen, Dominique Shum-Tim, Ray C J Chiu.   

Abstract

BACKGROUND: Myoblasts and stem cells implanted into myocardium can differentiate into myocytes and may functionally improve impaired ventricles. For implanted cells to actually contribute to the synchronous contractions of the heart, however, they must be anatomically integrated with the existing native myocardial fibers.
METHODS: Isogenic Lewis rats were used as donors and recipients to simulate clinical autotransplantation. Either skeletal myoblasts or marrow stromal stem cells were isolated from donors, culture expanded, and labeled with 4',6-diamidino-2-phenylindole (4',6-diamidino-2-phenylindole). Labeled cells were then injected into the myocardium of recipients. At intervals specimens were obtained, sectioned, and stained with hematoxylin and eosin and immunohistochemically against connexin-43 to demonstrate gap junctions (intercalated discs).
RESULTS: At 1 week the labeled cells were still undifferentiated, but early expression of connexin-43 could be detected at contact points between the implanted cells and the native myocytes. By 4 to 6 weeks, labeled, fully differentiated myocytes could be seen to interconnect among themselves and with native cardiomyocytes by means of intercalated discs. In sections parallel to the myofibers, full integration of new labeled myocytes with the native myofiber cells could be observed. Furthermore, the labeled myofibers were in parallel with the native, unlabeled fibers. We postulate that such supracellular structural integration was enhanced by fiber stretching during cardiac contractions, sending signals for cellular reorientation and incorporation, in which the cytoskeletal system may play an important role.
CONCLUSION: We conclude that implanted precursor cells can be integrated into native myocardial structure so as to contribute to myocardial function. Direct cell-to-cell contact seems to be an important signaling mechanism, which has implications for cellular implantation strategies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12202875     DOI: 10.1067/mtc.2002.122544

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  11 in total

Review 1.  Bone-marrow stem cells as a source for cell therapy.

Authors:  Ray C-J Chiu
Journal:  Heart Fail Rev       Date:  2003-07       Impact factor: 4.214

2.  Scarred myocardium imposes additional burden on remote viable myocardium despite a reduction in the extent of area with late contrast MR enhancement.

Authors:  Maythem Saeed; Randall J Lee; Oliver Weber; Loi Do; Alastair Martin; Philip Ursell; David Saloner; Charles B Higgins
Journal:  Eur Radiol       Date:  2005-12-16       Impact factor: 5.315

3.  Statins impair survival of primary human mesenchymal progenitor cells via mevalonate depletion, NF-κB signaling, and Bnip3.

Authors:  Yun Li; Alison L Müller; Melanie A Ngo; Kiranjit Sran; Daniel Bellan; Rakesh C Arora; Lorrie A Kirshenbaum; Darren H Freed
Journal:  J Cardiovasc Transl Res       Date:  2014-12-30       Impact factor: 4.132

4.  Calcium-sensing receptor-mediated mitogen-activated protein kinase pathway improves the status of transplanted mouse embryonic stem cells in rats with acute myocardial infarction.

Authors:  Jian Sun; Tao Wei; Shuzhi Bai; Hongtao Zhao; Xiaoqin Liu; Jinfeng Yu; Li Li; Gaochen Song; Hairong Luan; Changqing Xu
Journal:  Mol Cell Biochem       Date:  2017-03-09       Impact factor: 3.396

5.  Co-culture with cardiomyocytes enhanced the myogenic conversion of mesenchymal stromal cells in a dose-dependent manner.

Authors:  Xiao-Qing He; Min-Sheng Chen; Shu-Hong Li; Shi-Ming Liu; Yun Zhong; Heather Y McDonald Kinkaid; Wei-Yang Lu; Richard D Weisel; Ren-Ke Li
Journal:  Mol Cell Biochem       Date:  2010-01-10       Impact factor: 3.396

6.  Erythropoietin augments the efficacy of therapeutic angiogenesis induced by allogenic bone marrow stromal cells in a rat model of limb ischemia.

Authors:  Xiangqian Hou; Xuejun Wu; Junxi Ma; Xinhui Lv; Xing Jin
Journal:  Mol Biol Rep       Date:  2009-05-12       Impact factor: 2.316

Review 7.  Gene and cell therapy for heart failure.

Authors:  Ebo D de Muinck
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

8.  Cell tracking and therapy evaluation of bone marrow monocytes and stromal cells using SPECT and CMR in a canine model of myocardial infarction.

Authors:  Gerald Wisenberg; Katie Lekx; Pam Zabel; Huafu Kong; Rupinder Mann; Peter R Zeman; Sudip Datta; Caroline N Culshaw; Peter Merrifield; Yves Bureau; Glenn Wells; Jane Sykes; Frank S Prato
Journal:  J Cardiovasc Magn Reson       Date:  2009-04-27       Impact factor: 5.364

9.  Increased angiogenesis and improved left ventricular function after transplantation of myoblasts lacking the MyoD gene into infarcted myocardium.

Authors:  Yasuhiro Nakamura; Yoko Asakura; Bryan A Piras; Hiroyuki Hirai; Christopher T Tastad; Mayank Verma; Amanda J Christ; Jianyi Zhang; Takanori Yamazaki; Minoru Yoshiyama; Atsushi Asakura
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

10.  Interleukin-6 induces malignant transformation of rat mesenchymal stem cells in association with enhanced signaling of signal transducer and activator of transcription 3.

Authors:  Xiangrong Cui; Jianping Liu; Lu Bai; Jie Tian; Jing Zhu
Journal:  Cancer Sci       Date:  2013-12-30       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.